Regenerative therapy for cardiovascular disease
Tài liệu tham khảo
Go, 2013, Executive summary: heart disease and stroke statistics–2013 update: a report from the American Heart Association, Circulation, 127, 143, 10.1161/CIR.0b013e318282ab8f
McMurray, 2012, Eur Heart J, 33, 1787, 10.1093/eurheartj/ehs104
Beltrami, 2001, Evidence that human cardiac myocytes divide after myocardial infarction, N Engl J Med, 344, 1750, 10.1056/NEJM200106073442303
Quaini, 2002, Chimerism of the transplanted heart, N Engl J Med, 346, 5, 10.1056/NEJMoa012081
Jackson, 2001, Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells, J Clin Invest, 107, 1395, 10.1172/JCI12150
Mouquet, 2005, Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells, Circ Res, 97, 1090, 10.1161/01.RES.0000194330.66545.f5
Fazel, 2006, Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines, J Clin Invest, 116, 1865, 10.1172/JCI27019
Massa, 2005, Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction, Blood, 105, 199, 10.1182/blood-2004-05-1831
Leone, 2006, Endogenous G-CSF and CD34(+) cell mobilization after acute myocardial infarction, Int J Cardiol, 111, 202, 10.1016/j.ijcard.2005.06.043
Vandervelde, 2005, Signaling factors in stem cell-mediated repair of infarcted myocardium, J Mol Cell Cardiol, 39, 363, 10.1016/j.yjmcc.2005.05.012
Abbott, 2004, Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury, Circulation, 110, 3300, 10.1161/01.CIR.0000147780.30124.CF
Ferrari, 1998, Muscle regeneration by bone marrow-derived myogenic progenitors, Science, 279, 1528, 10.1126/science.279.5356.1528
Krause, 2001, Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell, Cell, 105, 369, 10.1016/S0092-8674(01)00328-2
Mezey, 2000, Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow, Science, 290, 1779, 10.1126/science.290.5497.1779
Orlic, 2001, Bone marrow cells regenerate infarcted myocardium, Nature, 410, 701, 10.1038/35070587
Fuchs, 2001, Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia, J Am Coll Cardiol, 37, 1726, 10.1016/S0735-1097(01)01200-1
Murry, 2004, Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts, Nature, 428, 664, 10.1038/nature02446
Zeng, 2007, Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling, Circulation, 115, 1866, 10.1161/CIRCULATIONAHA.106.659730
Uemura, 2006, Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling, Circ Res, 98, 1414, 10.1161/01.RES.0000225952.61196.39
Kamihata, 2001, Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines, Circulation, 104, 1046, 10.1161/hc3501.093817
Walter, 2005, Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease, Circ Res, 97, 1142, 10.1161/01.RES.0000193596.94936.2c
Anversa, 2013, Regenerating new heart with stem cells, J Clin Invest, 123, 62, 10.1172/JCI63068
Suzuki, 2009, Pravastatin improves function in hibernating myocardium by mobilizing CD133+ and cKit+ bone marrow progenitor cells and promoting myocytes to reenter the growth phase of the cardiac cell cycle, Circ Res, 104, 255, 10.1161/CIRCRESAHA.108.188730
Asahara, 1999, Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization, Circ Res, 85, 221, 10.1161/01.RES.85.3.221
Dai, 2005, Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects, Circulation, 112, 214, 10.1161/CIRCULATIONAHA.104.527937
Shake, 2002, Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects, Ann Thorac Surg, 73, 1919, 10.1016/S0003-4975(02)03517-8
Herreros, 2003, Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction, Eur Heart J, 24, 2012, 10.1016/j.ehj.2003.09.012
Perin, 2003, Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure, Circulation, 107, 2294, 10.1161/01.CIR.0000070596.30552.8B
Strauer, 2002, Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans, Circulation, 106, 1913, 10.1161/01.CIR.0000034046.87607.1C
Zimmet, 2012, Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials, Eur J Heart Fail, 14, 91, 10.1093/eurjhf/hfr148
Perin, 2004, Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy, Circulation, 110, II213, 10.1161/01.CIR.0000138398.77550.62
Schachinger, 2004, Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial, J Am Coll Cardiol, 44, 1690, 10.1016/j.jacc.2004.08.014
Wollert, 2004, Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial, Lancet, 364, 141, 10.1016/S0140-6736(04)16626-9
Schachinger, 2006, Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction, N Engl J Med, 355, 1210, 10.1056/NEJMoa060186
Lunde, 2006, Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction, N Engl J Med, 355, 1199, 10.1056/NEJMoa055706
Janssens, 2006, Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial, Lancet, 367, 113, 10.1016/S0140-6736(05)67861-0
Roncalli, 2011, Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial, Eur Heart J, 32, 1748, 10.1093/eurheartj/ehq455
Hirsch, 2011, Eur Heart J, 32, 1736, 10.1093/eurheartj/ehq449
Perin, 2012, Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial, JAMA, 307, 1717, 10.1001/jama.2012.418
Seeger, 2007, Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction, Eur Heart J, 28, 766, 10.1093/eurheartj/ehl509
Assmus, 2010, Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy, J Am Coll Cardiol, 55, 1385, 10.1016/j.jacc.2009.10.059
Bartunek, 2006, Timing of intracoronary bone-marrow-derived stem cell transplantation after ST-elevation myocardial infarction, Nat Clin Pract Cardiovasc Med, 3, S52, 10.1038/ncpcardio0417
Moelker, 2006, Reduction in infarct size, but no functional improvement after bone marrow cell administration in a porcine model of reperfused myocardial infarction, Eur Heart J, 27, 3057, 10.1093/eurheartj/ehl401
de Silva, 2008, Eur Heart J, 29, 1772, 10.1093/eurheartj/ehn216
Schuleri, 2009, Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy, Eur Heart J, 30, 2722, 10.1093/eurheartj/ehp265
Williams, 2013, Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction, Circulation, 127, 213, 10.1161/CIRCULATIONAHA.112.131110
Dawn, 2005, Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function, Proc Natl Acad Sci U S A, 102, 3766, 10.1073/pnas.0405957102
Bolli, 2013, Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy, Circulation, 128, 122, 10.1161/CIRCULATIONAHA.112.001075
Johnston, 2009, Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy, Circulation, 120, 1075, 10.1161/CIRCULATIONAHA.108.816058
Lee, 2011, Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction, J Am Coll Cardiol, 57, 455, 10.1016/j.jacc.2010.07.049
Nelson, 2009, Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells, Circulation, 120, 408, 10.1161/CIRCULATIONAHA.109.865154
Mauritz, 2011, Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction, Eur Heart J, 32, 2634, 10.1093/eurheartj/ehr166
Li, 2013, Intramyocardial Injection of Pig Pluripotent Stem Cells Improves Left Ventricular Function and Perfusion: A Study in a Porcine Model of Acute Myocardial Infarction, PloS one, 8, e66688, 10.1371/journal.pone.0066688
Rajasingh, 2007, STAT3-dependent mouse embryonic stem cell differentiation into cardiomyocytes: analysis of molecular signaling and therapeutic efficacy of cardiomyocyte precommitted mES transplantation in a mouse model of myocardial infarction, Circ Res, 101, 910, 10.1161/CIRCRESAHA.107.156786
Meyer, 2006, Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial, Circulation, 113, 1287, 10.1161/CIRCULATIONAHA.105.575118
Traverse, 2011, Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial, JAMA, 306, 2110, 10.1001/jama.2011.1670
Traverse, 2012, Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial, JAMA, 308, 2380, 10.1001/jama.2012.28726
Bartunek, 2013, Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics, J Am Coll Cardiol, 61, 2329, 10.1016/j.jacc.2013.02.071
Hare, 2012, Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial, JAMA, 308, 2369, 10.1001/jama.2012.25321
Bolli, 2011, Cardiac Stem Cells in Patients with Ischaemic Cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial, Lancet, 378, 1847, 10.1016/S0140-6736(11)61590-0
Malliaras, 2013, Intracoronary cardiosphere-derived cells after myocardial infarction: evidence for therapeutic regeneration in the final 1-year results of the CADUCEUS trial, J Am Coll Cardiol, 10.1016/S0735-1097(13)60105-9
Penicka, 2005, Images in cardiovascular medicine: early tissue distribution of bone marrow mononuclear cells after transcoronary transplantation in a patient with acute myocardial infarction, Circulation, 112, e63, 10.1161/CIRCULATIONAHA.104.496133
Muller-Ehmsen, 2006, Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction, J Mol Cell Cardiol, 41, 876, 10.1016/j.yjmcc.2006.07.023
Dimmeler, 2008, Aging and disease as modifiers of efficacy of cell therapy, Circ Res, 102, 1319, 10.1161/CIRCRESAHA.108.175943
Mohsin, 2011, Empowering adult stem cells for myocardial regeneration, Circ Res, 109, 1415, 10.1161/CIRCRESAHA.111.243071
Jakob, 2012, Role of microRNAs in stem/progenitor cells and cardiovascular repair, Cardiovasc Res, 93, 614, 10.1093/cvr/cvr311
Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143
Makino, 1999, Cardiomyocytes can be generated from marrow stromal cells in vitro, J Clin Invest, 103, 697, 10.1172/JCI5298
Xu, 2004, Differentiation of bone marrow stromal cells into the cardiac phenotype requires intercellular communication with myocytes, Circulation, 110, 2658, 10.1161/01.CIR.0000145609.20435.36
Toma, 2002, Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart, Circulation, 105, 93, 10.1161/hc0102.101442
Quevedo, 2009, Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity, Proc Natl Acad Sci U S A, 106, 14022, 10.1073/pnas.0903201106
Makkar, 2005, Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction, J Cardiovasc Pharmacol Ther, 10, 225, 10.1177/107424840501000403
Yang, 2009, Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts, Arterioscler Thromb Vasc Biol, 29, 2076, 10.1161/ATVBAHA.109.189662
Dixon, 2009, Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction, Circulation, 120, S220, 10.1161/CIRCULATIONAHA.108.842302
Perin, 2008, Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction, J Mol Cell Cardiol, 44, 486, 10.1016/j.yjmcc.2007.09.012
Halkos, 2008, Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction, Basic Res Cardiol, 103, 525, 10.1007/s00395-008-0741-0
Iso, 2007, Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment, Biochem Biophys Res Commun, 354, 700, 10.1016/j.bbrc.2007.01.045
Leiker, 2008, Assessment of a nuclear affinity labeling method for tracking implanted mesenchymal stem cells, Cell Transplant, 17, 911, 10.3727/096368908786576444
Kinnaird, 2004, Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms, Circ Res, 94, 678, 10.1161/01.RES.0000118601.37875.AC
Gnecchi, 2005, Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells, Nat Med, 11, 367, 10.1038/nm0405-367
Gnecchi, 2008, Paracrine mechanisms in adult stem cell signaling and therapy, Circ Res, 103, 1204, 10.1161/CIRCRESAHA.108.176826
Dominici, 2006, Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement, Cytotherapy, 8, 315, 10.1080/14653240600855905
Williams, 2011, Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease, Circ Res, 109, 923, 10.1161/CIRCRESAHA.111.243147
Chen, 2004, Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction, Am J Cardiol, 94, 92, 10.1016/j.amjcard.2004.03.034
Hare, 2009, A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction, J Am Coll Cardiol, 54, 2277, 10.1016/j.jacc.2009.06.055
Williams, 2011, Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling, Circ Res, 108, 792, 10.1161/CIRCRESAHA.111.242610
Behfar, 2010, Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction, J Am Coll Cardiol, 56, 721, 10.1016/j.jacc.2010.03.066
Hierlihy, 2002, The post-natal heart contains a myocardial stem cell population, FEBS Lett, 530, 239, 10.1016/S0014-5793(02)03477-4
Pfister, 2008, Role of the ATP-binding cassette transporter Abcg2 in the phenotype and function of cardiac side population cells, Circ Res, 103, 825, 10.1161/CIRCRESAHA.108.174615
Goodell, 1996, Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo, J Exp Med, 183, 1797, 10.1084/jem.183.4.1797
Asakura, 2002, Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation, Exp Hematol, 30, 1339, 10.1016/S0301-472X(02)00954-2
Challen, 2006, A side order of stem cells: the SP phenotype, Stem Cells, 24, 3, 10.1634/stemcells.2005-0116
Pfister, 2005, CD31– but not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation, Circ Res, 97, 52, 10.1161/01.RES.0000173297.53793.fa
Oyama, 2007, Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo, J Cell Biol, 176, 329, 10.1083/jcb.200603014
Martin, 2004, Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart, Dev Biol, 265, 262, 10.1016/j.ydbio.2003.09.028
Yoon, 2007, Cardiac side population cells exhibit endothelial differentiation potential, Exp Mol Med, 39, 653, 10.1038/emm.2007.71
Liang, 2010, Differentiation and migration of Sca1+/CD31– cardiac side population cells in a murine myocardial ischemic model, Int J Cardiol, 138, 40, 10.1016/j.ijcard.2008.08.032
Oh, 2003, Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction, Proc Natl Acad Sci U S A, 100, 12313, 10.1073/pnas.2132126100
Beltrami, 2003, Adult cardiac stem cells are multipotent and support myocardial regeneration, Cell, 114, 763, 10.1016/S0092-8674(03)00687-1
Messina, 2004, Isolation and expansion of adult cardiac stem cells from human and murine heart, Circ Res, 95, 911, 10.1161/01.RES.0000147315.71699.51
van Vliet, 2008, Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy, Netherl Heart J, 16, 163, 10.1007/BF03086138
Ellison, 2013, Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair, Cell, 154, 827, 10.1016/j.cell.2013.07.039
Hsieh, 2007, Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury, Nat Med, 13, 970, 10.1038/nm1618
Bergmann, 2009, Evidence for cardiomyocyte renewal in humans, Science, 324, 98, 10.1126/science.1164680
Laflamme, 2005, Regenerating the heart, Nat Biotechnol, 23, 845, 10.1038/nbt1117
Tang, 2010, Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction, Circulation, 121, 293, 10.1161/CIRCULATIONAHA.109.871905
Chugh, 2012, Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance, Circulation, 126, S54, 10.1161/CIRCULATIONAHA.112.092627
Makkar, 2012, Intracoronary Cardiosphere-Derived Cells for Heart Regeneration After Myocardial Infarction (CADUCEUS): a prospective, randomised phase 1 trial, Lancet, 379, 895, 10.1016/S0140-6736(12)60195-0
Meissner, 2006, The ATP-binding cassette transporter ABCG2 (BCRP), a marker for side population stem cells, is expressed in human heart, J Histochem Cytochem, 54, 215, 10.1369/jhc.5A6750.2005
Linke, 2005, Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function, Proc Natl Acad Sci U S A, 102, 8966, 10.1073/pnas.0502678102
Matsuura, 2004, Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes, J Biol Chem, 279, 1384, 10.1074/jbc.M310822200
Wang X, Hisha H, Taketani S, et al. Characterization of mesenchymal stem cells isolated from mouse fetal bone marrow. Stem Cells 24;482–93.
Laugwitz, 2005, Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages, Nature, 433, 647, 10.1038/nature03215
Moretti, 2006, Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification, Cell, 127, 1151, 10.1016/j.cell.2006.10.029
Ott, 2007, The adult human heart as a source for stem cells: repair strategies with embryonic-like progenitor cells, Nat Clin Pract Cardiovasc Med, 4, S27, 10.1038/ncpcardio0771
Hou, 2012, Isolation, Characterization, and Spatial Distribution of Cardiac Progenitor Cells in the Sheep Heart, J clin Exp Cardiology, S6
Smith, 2007, Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens, Circulation, 115, 896, 10.1161/CIRCULATIONAHA.106.655209
Limana, 2007, Identification of myocardial and vascular precursor cells in human and mouse epicardium, Circ Res., 101, 1255, 10.1161/CIRCRESAHA.107.150755
Ruiz-Villalba, 2013, Characterization of epicardial-derived cardiac interstitial cells: differentiation and mobilization of heart fibroblast progenitors, PloS one, 8, e53694, 10.1371/journal.pone.0053694
Kehat, 2001, Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes, J Clin Invest, 108, 407, 10.1172/JCI200112131
Mauritz, 2008, Generation of functional murine cardiac myocytes from induced pluripotent stem cells, Circulation, 118, 507, 10.1161/CIRCULATIONAHA.108.778795
Westfall, 1997, Ultrastructure and cell-cell coupling of cardiac myocytes differentiating in embryonic stem cell cultures, Cell Motil Cytoskel, 36, 43, 10.1002/(SICI)1097-0169(1997)36:1<43::AID-CM4>3.0.CO;2-I
Jonsson, 2012, Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG, J Mol Cell Cardiol, 52, 998, 10.1016/j.yjmcc.2012.02.002
Laflamme, 2005, Formation of human myocardium in the rat heart from human embryonic stem cells, Am J Pathol, 167, 663, 10.1016/S0002-9440(10)62041-X
Tomescot, 2007, Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats, Stem Cells, 25, 2200, 10.1634/stemcells.2007-0133
Ardehali, 2013, Prospective isolation of human embryonic stem cell-derived cardiovascular progenitors that integrate into human fetal heart tissue, Proc Natl Acad Sci U S A, 110, 3405, 10.1073/pnas.1220832110
Wakitani, 2003, Embryonic stem cells injected into the mouse knee joint form teratomas and subsequently destroy the joint, Rheumatology, 42, 162, 10.1093/rheumatology/keg024
Okita, 2007, Generation of germline-competent induced pluripotent stem cells, Nature, 448, 313, 10.1038/nature05934
Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019
Kawamura, 2012, Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model, Circulation, 126, S29, 10.1161/CIRCULATIONAHA.111.084343
Ieda, 2010, Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors, Cell, 142, 375, 10.1016/j.cell.2010.07.002
Song, 2012, Heart repair by reprogramming non-myocytes with cardiac transcription factors, Nature, 485, 599, 10.1038/nature11139
Ahmed, 2011, Cardiac tumorigenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction, Regen Med, 6, 171, 10.2217/rme.10.103